Patent Assignment
Reel/Frame 033162/0807
Assignment of Assignor's Interest
Recorded: 2014-06-11
Pages: 5
Assignor
THERAVANCE, INC.
Executed: 2014-06-01
Assignee
THERAVANCE BIOPHARMA R&D IP, LLC
901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, CALIFORNIA, USA 94080
Covered Properties
(7)
Muscarinic Receptor Antagonists
Application:
09/325,725 →
Muscarinic Receptor Antagonists
Application:
09/456,170 →
Muscarinic Receptor Antagonists
Patent:
6,693,202 →
Application:
09/645,609 →
Muscarinic receptor antagonists
Application:
09/719,054 →
Muscarinic Receptor Antagonists
Muscarinic receptor antagonists
Application:
12/286,528 →
Publication:
US 2009/0306134
Muscarinic Receptor Antagonists
Application:
60/120,287 →
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 13, 2000
From: AGGEN, JAMES; GRIFFIN, JOHN H.; MAMMEN, MATHAI; MARQUESS, DANIEL
To: ADVANCED MEDICINE, INC.
Reel/Frame 011365/0621 →
Assignment of Assignor's Interest
Sep 28, 2001
From: MAMMEN, MATHAI; OARE, DAVID; GRIFFIN, JOHN H.; AGGEN, JAMES
To: ADVANCED MEDICINE, INC.
Reel/Frame 012236/0156 →
Merger
Jun 13, 2002
From: ADVANCED MEDICINE, INC.
To: THERAVANCE, INC.
Reel/Frame 013017/0267 →
Assignment of Assignor's Interest
Aug 5, 2003
From: AGGEN, JAMES B.; GRIFFIN, JOHN H.; MAMMEN, MATHAI; MARQUESS, DANIEL
To: THERAVANCE, INC.
Reel/Frame 013857/0214 →
Corrective Assignment Document Submitted to Correct Title of Patent Application, I.E. the Term "Agonists" Has Been Corrected to "Antagonists".the Original Assignment Document Was Record on August 5, 2003 at Reel 013857 Frame 0214.
Nov 21, 2003
From: AGGEN, JAMES B.; GRIFFIN, JOHN H.; MAMMEN, MATHAI; MARQUESS, DANIEL
To: THERAVANCE, INC.
Reel/Frame 014148/0582 →
Acknowledgment of Security Interest in Intellectual Property
Jun 29, 2018
From: SUN HYDRAULICS CORPORATION; ENOVATION CONTROLS, LLC; SUN HYDRAULICS, LLC
To: PNC BANK, NATIONAL ASSOCIATION
Reel/Frame 046468/0256 →